Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of the current study is to investigate the bioavailability of BI 10773 and of
warfarin after concomitant multiple oral administration of BI 10773 and a single oral dose of
warfarin in comparison to BI 10773 and warfarin given alone, and to investigate the
pharmacodynamics of a single oral dose of warfarin with and without concomitant multiple oral
administration of BI 10773.